MG
XLRN

Michael Gelband’s Acceleron Pharma XLRN Stock Holding History

Michael Gelband’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,318
Closed -$227K – 2808
2021
Q3 		$227K Sell
1,318
-2,647
-67% -$346K ﹤0.01% 1738
2021
Q2 		$498K Buy
+3,965
New +$500K 0.01% 1438
2020
Q3 		– Sell
-31,242
Closed -$2.98M – 2401
2020
Q2 		$2.98M Buy
+31,242
New +$3.01M 0.08% 293

Michael Gelband's XLRN Position: Q4 2021 in Review

Michael Gelband sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,318 shares — an estimated $227K sold.

Michael Gelband first reported a position in XLRN in Q2 2020 and held it in 3 quarters. The position peaked at $2.98M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Michael Gelband reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 1,318 Acceleron Pharma shares in Q4 2021, an estimated $227K.
  • Michael Gelband first reported a position in Acceleron Pharma in Q2 2020 and held it in 3 quarters.
  • Michael Gelband's Acceleron Pharma position peaked at $2.98M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.